Estate Counselors’s AbbVie ABBV Stock Holding History

Estate Counselors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,290	Closed	-$1.34M	–	127
2022 Q4	$1.34M	Buy	+8,290	New	+$1.27M	0.19%	76

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Estate Counselors's ABBV Position: Q1 2023 in Review

Estate Counselors sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 8,290 shares — an estimated $1.34M sold.

Estate Counselors first reported a position in ABBV in Q4 2022 and held it in 1 quarter. The position peaked at $1.34M in Q4 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Estate Counselors reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Estate Counselors sold 8,290 AbbVie shares in Q1 2023, an estimated $1.34M.
Estate Counselors first reported a position in AbbVie in Q4 2022 and held it in 1 quarter.
Estate Counselors's AbbVie position peaked at $1.34M in Q4 2022.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Estate Counselors's 13F filing for Q1 2023, filed 4 May 2023.